Share

    


In This Section

Home / News & Media / Coronavirus Response

Coronavirus Response

When the coronavirus disease began to spread widely in the United States, ACCC members on the frontlines of the pandemic came together as a community to share their perspective and lessons learned by participating in ACCC webcasts, mini-podcasts, and blog posts. The educational resources included in this COVID-19 Resource Center represent the expertise, dedication, and generosity of ACCC members across the nation who have been deeply involved in caring for patients and establishing protocols for virus response since March 2020.

On January 7, 2021, U.S. Department of Health and Human Services (HHS) Secretary Alex Azar signed an extension of the COVID-19 public health emergency (PHE) designation until April 21, 2021. ACCC resources from the pandemic's acute phase and pre-vaccination phase are accessible to help cancer programs and practices that still face many pressing issues related to COVID-19.

COVID-19 On-Demand Webinar 

COVID-19 Implications for Cancer Clinical Research and Quality Care

An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.

COVID-19 Resources 

HHS-60x60combatCOVID.hhs.gov provides important information and links to access the most current treatment guidelines and inpatient and outpatient clinical trials.

AMCCBS Virtual 

In the wake of COVID-19, seismic changes in the healthcare sector have pushed cancer care providers to continue to prove their resiliency and ability to quickly adapt to change. At the ACCC 47th Annual Meeting & Cancer Center Business Summit, March 1 – 5, hear real-world examples from institutions that have used the opportunity created by this pandemic to forge a new path forward.

  • Cancer Care in the COVID-19 Era
  • Issue of the Day: COVD-19 Networking Event
  • Virtual Solutions: Oncology Telemedicine for Rural Communities
  • Cancer Care During the Pandemic: The Good, the Bad, and the Ugly from the Patient Perspective
  • Prevention on the Go—Workplace
  • Experience of a Large Cancer Center Adjusting to COVID-19

View the complete agenda to explore additional sessions detailing the impact of COVID-19 on programs and practices across the U.S.
Reserve Your Seat Today

Financial Resources 

The ACCC Financial Advocacy Network developed the COVID-19 Financial Advocacy Resources hub to help cancer programs and practices to stay informed on rapidly changing updates to financial assistance programs and insurance coverage in response to the public health emergency. This resource will be reviewed and updated weekly.

Telehealth 

Adoption & Expansion of Telehealth Solutions addresses the immediate and ongoing needs of cancer programs and practices that want to implement, integrate, and expand their telehealth services to optimize patient care during the current public health emergency and beyond. Through this effort, ACCC will help guide members of the multidisciplinary team in the areas of rapid response, policy rules and regulations, team-based telehealth delivery, technology needs, and actionable blueprints to build new telehealth solutions.

COVID-19 Webcasts 

  • Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client & Corporate Resources, Revenue Cycle Coding Strategies, highlights what your cancer program needs to know by discussing the changes to telehealth services, supervision, provider-based designations, and coding for services. (July 10, 2020)

  • Deirdre Saulet, Advisory Board Company, and Amanda Henson, MSHA, MBA, FACHE, Baptist Health, share an overview of programs’ volumes in response to COVID-19, effective staffing strategies, tactics for supporting your care team, and how to prepare for potential future ‘waves’. (May 29, 2020)

  • Jenna VanGilder, MHA, RN, OCN, CENP, Edward Elmhurst Health, shares best practices in treating COVID+ patients with cancer, including the use of screening algorithms, approaches to patient and staff protection, communications planning. (May 1, 2020)

Presentation 

Covid Poster Presentation

COVID-19 Podcasts 

 

  • [PODCAST] Episode 28: Telehealth & Genetics During COVID-19
    Feb 23, 2021

    Learn how genetic healthcare services have adapted to virtual care delivery, and what challenges face its widespread use after the COVID-19 pandemic is over.

  • [PODCAST] Mini-Podcast: Supporting Caregivers During COVID-19
    Dec 22, 2020

    Learn how the role of caregivers has changed during the pandemic, and how the cancer team can provide caregivers with guidance on taking care of patients with cancer.

  • [PODCAST] Mini-Podcast: Psychosocial Oncology Services During COVID-19
    Dec 15, 2020

    We explore how patients are dealing with the "new normal,” and how oncology social workers, psychologists, and psychiatrists are working to help them through an unprecedented time.

  • [PODCAST] Mini-Podcast: Cancer Screening During COVID-19
    Jul 20, 2020

    Learn how some cancer programs are finding creative ways to engage patients and adapt screening programs during these difficult times.

  • [PODCAST] Mini-Podcast: Staff Resiliency During COVID-19
    Jul 7, 2020

    Krista Nelson, ACCC President 2021-22, shares how Providence Cancer Institute has made staff resiliency and morale a priority during the COVID-19 pandemic.

  • [PODCAST] Mini-Podcast: COVID-19 & Music Therapy
    Apr 28, 2020

    Learn how music can help relieve coronavirus-related stress for both patients and cancer program staff.

  • [PODCAST] Mini-Podcast: COVID-19 & Oral Oncolytics
    Apr 14, 2020

    We explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.

  • [PODCAST] Mini-Podcast: COVID-19 Conversations with Patients
    Apr 7, 2020

    Jeffrey Kendall, PsyD, LP, shares useful tips and resources for compassionate communication with patients during the COVID-19 pandemic.

  • [PODCAST] Mini-Podcast: COVID-19 Self-Care
    Mar 31, 2020

    Krista Nelson, ACCC President 2021-22, shares self-care resources for cancer team members during the COVID-19 outbreak and guides us through a brief mindfulness exercise.

ASCO COVID-19 REGISTRY  

ASCO-Registry-191x30The ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) is aimed to help ASCO examine the evidence on the effect of COVID-19 on patients with cancer. The ASCO Registry collects baseline and longitudinal data on patients with cancer and COVID-19 and plans to deliver periodic reports with key findings that can influence future care. The greater diversity and number of patients the Registry represents, the more we can learn from this unique experience in cancer care. Join the Registry.

 

Publications 

Telehealth At Its Best ThumbnailTelehealth at Its Best: Transitioning a Comprehensive Psychosocial Program to a Virtual Format
Due to the COVID-19 pandemic and its associated risks for patients with cancer, all Life with Cancer programming was cancelled on Mar. 12, 2020. Staff, struggling with their own anxiety over personal safety, quickly went into action on how best to continue to meet the psychological and educational needs of patients and families.

The Road To Recovery ThumbnailCancer & COVID-19: The Road to Recovery (ASCO Publication)
Recommendations for Post-Pandemic Cancer Care and Research
  • Telemedicine and Cancer Care Bashur
    Telemedicine and Cancer Care: Today’s Learnings for a Post-Pandemic World
    Nov 20, 2020

    Despite a century-long history and a substantial body of recent empirical evidence that attests to its clinical and economic effectiveness and improved access, telemedicine has yet to become a routine part of clinical practice for the majority of clinicians. If used appropriately, it can serve as an effective substitute for in-person care which does not require physical examination in nearly all facets of the medical care process, including prevention, diagnosis, treatment, monitoring, and follow-up.

  • Patients Receiving Anti Cancer Immunotherapy
    COVID-19 and Patients Receiving Anticancer Immunotherapy
    Nov 20, 2020

    SARS-CoV-2 and the resulting respiratory tract infection COVID-19 has upended our society and forcefully changed the way we care for patients. Since the emergence of the virus in early 2020, there have been questions surrounding the risk posed to patients with a cancer diagnosis and the safety of anticancer therapies. 

Page last updated Feb 11, 2021